Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Marco Metra
Session number: 902
Session title: The European Heart Journal’s / European Journal of Heart Failure’s year in Cardiology
Authors: Marco Metra (Brescia, Italy)
This session was aimed at showing the most significant articles published in the last year in the European Heart Journal and European Journal of Heart Failure. Prof Thomas Luescher introduced the topic, showing the family of European Society of Cardiology (ESC) affiliated journals, now also including the European Heart Journal: Cardiovascular Pharmacotherapy, the European Heart Journal: Quality of Care and Clinical Outcomes, and the open access journal ESC Heart Failure. He also showed the rapidly increasing impact factor of the European Heart Journal (EHJ), bringing it to the top level among cardiology journals, as well as the improvement of all the affiliated journals, with the European Journal of Heart Failure ranking first among heart failure (HF) journals.
Fausto Pinto summarized the main progress in cardiovascular imaging for HF, including the application of techniques to detect more subtle abnormalities of left ventricular (LV) function such as LV global longitudinal strain, speckle-tracking strain analysis, cardiac magnetic resonance imaging with late gadolinium enhancement and stress test to assess LV diastolic function.
Piotr Ponikowski showed the recently published epidemiological data regarding HF in France, namely the CardShock study, analyzing the prognostic value of the response to diuretic therapy in acute HF. The recently issued recommendations about the management of acute HF were also highlighted.
Data regarding the clinical and prognostic significance of iron deficiency and the beneficial effects of iron therapy with ferric carboxymaltose were shown by both Prof. Ponikowski and Prof. John McMurray. John McMurray also presented data regarding the effects of LCZ696 administration in patients with HF, as well as a review of the development of this new compound. Disease management programs were also analyzed.
Lastly, Kenneth Dickstein focused on devices in HF treatment, considering the interatrial septal device for HF with high intra-atrial pressure, the mitra-clip system for mitral regurgitation, PARACHUTE implantation for LV aneurysm, chronic baroreflex activation, pump speed modulation of LV assist device (LVAD), and the effects of LVAD on diabetic control. To finish, the effects of cardiac resynchronization therapy in milder LV dysfunction and after right ventricular pacing were shown.